Carregant...
Emerging infection and sepsis biomarkers: will they change current therapies?
INTRODUCTION: Sepsis is a heterogeneous syndrome characterized by both immune hyperactivity and relative immune suppression. Biomarkers have the potential to improve recognition and management of sepsis through three main applications: diagnosis, monitoring response to treatment, and stratifying pat...
Guardat en:
| Publicat a: | Expert Rev Anti Infect Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5087989/ https://ncbi.nlm.nih.gov/pubmed/27533847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14787210.2016.1222272 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|